T 1815/22 (Antibody variants/GLAXOSMITHKLINE) of 12.12.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T181522.20241212
- Date of decision
- 12 December 2024
- Case number
- T 1815/22
- Petition for review of
- -
- Application number
- 16760801.7
- IPC class
- C07K 16/24C07K 1/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Biopharmaceutical compositions
- Applicant name
- GlaxoSmithKline Intellectual Property (No.2) Limited
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 84
- Keywords
- Claims - clarity
Claims - main request (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution on the basis of the main request filed with the statement of grounds of appeal.